Antiarrhythmic properties of a rapid delayed-rectifier current activator in rabbit models of acquired long QT syndrome.
about
Translational toxicology and rescue strategies of the hERG channel dysfunction: biochemical and molecular mechanistic aspectsPharmacological treatment of acquired QT prolongation and torsades de pointes.Assessment of the Spatial QRS-T Angle by Vectorcardiography: Current Data and Perspectives.Differential effects of Kv11.1 activators on Kv11.1a, Kv11.1b and Kv11.1a/Kv11.1b channelsMolecular determinants of human ether-à-go-go-related gene 1 (hERG1) K+ channel activation by NS1643Effects of the small molecule HERG activator NS1643 on Kv11.3 channels.Cardiac ventricular repolarization reserve: a principle for understanding drug-related proarrhythmic risk.Potassium channel activation inhibits proliferation of breast cancer cells by activating a senescence programThe spatial QRS-T angle: implications in clinical practice.HERG1 channel agonists and cardiac arrhythmia.Cardiac slices as a predictive tool for arrhythmogenic potential of drugs and chemicals.K(+) channels: function-structural overview.Cardiac potassium channel subtypes: new roles in repolarization and arrhythmia.Post-acute management of the acquired long QT syndrome.hERG1 potassium channel in cancer cells: a tool to reprogram immortality.AV-block and conduction slowing prevail over TdP arrhythmias in the methoxamine-sensitized pro-arrhythmic rabbit model.Modulation of Kv 11.1 (hERG) channels by 5-(((1H-indazol-5-yl)oxy)methyl)-N-(4-(trifluoromethoxy)phenyl)pyrimidin-2-amine (ITP-2), a novel small molecule activator.NS1643 enhances ionic currents in a G604S-WT hERG co-expression system associated with long QT syndrome 2.Regulation and physiological function of Nav1.5 and KCNQ1 channels
P2860
Q27008208-897F8122-5A40-4758-83C9-8EA7E266A17AQ33166019-43E60CEC-4E33-4F6E-97CB-3F00E276F53EQ33734668-848DDB97-98F2-4655-8550-1D5F18974E5CQ34342271-1A3C5607-B2F5-42F7-998A-F32AC223889CQ34458432-E11C80FB-ABF9-4012-A10E-FBEAB9E2F90BQ34506112-55E0A3DB-18ED-4C8E-AA0E-5D6DF404C672Q35210010-24C4D6DD-F5F1-4068-AB14-51E1793108DAQ36973723-9C81A726-9645-44DE-9D42-709D4465EEAFQ37190416-3794A61A-AC3F-4C77-9135-237F6967306EQ37699209-3419498C-4149-474D-9AAB-00A64CA32869Q37808482-624E46EB-B693-46B7-A3FE-FB97FA5F24F0Q38110757-092EB1B3-E335-42E2-A3B9-B7FDC5299000Q38201409-4570CAD6-3187-4062-B0DA-3E4407428EF9Q38201702-55A6FCD8-DC3D-4BE6-AA89-E46D1C349CEBQ38959783-C5FF6B85-6AFC-4941-A6FE-55841D59B631Q47824791-443E869E-9A0E-48DA-8BAB-14E0E5BC5A43Q48149063-5C524E58-4579-47A8-A4AE-29636F8960C6Q48352073-639EACF2-CB3F-4ECB-8D9C-48714CB24AD5Q57805857-470E48B9-7307-41D4-8E95-2F0B0F6E2438
P2860
Antiarrhythmic properties of a rapid delayed-rectifier current activator in rabbit models of acquired long QT syndrome.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Antiarrhythmic properties of a ...... of acquired long QT syndrome.
@en
Antiarrhythmic properties of a ...... of acquired long QT syndrome.
@nl
type
label
Antiarrhythmic properties of a ...... of acquired long QT syndrome.
@en
Antiarrhythmic properties of a ...... of acquired long QT syndrome.
@nl
prefLabel
Antiarrhythmic properties of a ...... of acquired long QT syndrome.
@en
Antiarrhythmic properties of a ...... of acquired long QT syndrome.
@nl
P2093
P2860
P356
P1476
Antiarrhythmic properties of a ...... of acquired long QT syndrome.
@en
P2093
Denis Chartier
Morten Grunnet
Rie S Hansen
Soren-Peter Olesen
Thomas G Diness
Xiao Yan Qi
Yukiomi Tsuji
Yung-Hsin Yeh
P2860
P356
10.1093/CVR/CVN075
P577
2008-03-26T00:00:00Z